Cancer Treatment Today

OVA1 test is FDA cleared for women who meet the following criteria: (i) over age 18, (ii) ovarian adnexal mass present for which surgery is planned, and (iii) not yet referred to an oncologist. It is an aid to further assess the likelihood that malignancy is present when the physician’s independent clinical and radiological evaluation does not indicate malignancy. The test should not be used without an independent clinical/radiological evaluation

This is a 3D medical animation that helps to explain the answer to the question "what is cancer?" Thank you to biodigitalsystems for allowing us to share this video.

In this video, you will see how a Killer T Cell attacks Cancer. This video is courtesy of Cambridge University.

Charged-particle beams consisting of protons or helium ions are a type of radiation therapy that uses particles which is different from conventional radiation that uses electromagnetic (i.e., photon) radiation. Particles have the unique properties of minimal scatter as the particulate beams pass through the tissue. As such, there is less “collateral damage” to the surrounding tissue and it is possible to ensure a more precise deposition of the

There are now five different classes of drugs with significant antitumor activity in colon cancer: Fluoropyrimidine(5-fluorouracil [5-FU] which is usually given with leucovorin [LV], capecitabine, tegafur plus uracil [UFT]), Irinotecan, Oxaliplatin, Cetuximab and panitumumab (Vectbix). The latter two are monoclonal antibodies (MoAbs) directed against the epidermal growth factor receptor (EGFR), and bevacizumab, is a monoclonal antibody targeting

Is there a way to make cancers that stop responding to hormones increase their sensitivity to these drugs? Preclinical evidence suggests Herceptin (trustusumab) can restore and amplify responsiveness to hormonal therapy. The combination of Tykerb, which like Herceptin works on the HER receptor, and Femara is FDA approved and is thought to work through this mechanism. A randomized phase III TAnDEM study investigated Trastuzumab plus Arimidex(anastrozole)

Tarceva (erlotinib) is FDA approved for non-small cell lung cancer after standard chemo has failed. Older studies showed that it does not contribute to chemotherapy in first-line. It is being studied for first line therapy of lung cancer instead of chemotherapy. This drug has been studied primarily in stage IV, when it has spread but recently it has been also studied, for maintenance, once treatment with chemotherapy had stopped. Maintenance means

Magnetic Resonance Imaging (MRI) of the brain is useful in the diagnosis and treatment of multiple sclerosis (MS), because it is an inflammatory, demyelinating condition of the central nervous system (CNS) that MRI can visualize. Therefore, the activity of the disease can be quantified and tracked over time, with treatment. White matter tracts are affected, including those of the upper brain, lower brain, and spinal cord. MS lesions, known as plaques,

ALL is the most common cancer diagnosed in children and young adults, represents almost 25% of cancers in children younger than 15 years. Complete remission of disease is now typically achieved with pediatric chemotherapy regimens in approximately 95% of children with ALL, with up to 85% long-term survival rates. Young adults are treated as children, but the relapse rate is higher.  Allogeneic stem cell transplantation is an important salvage option

The post transplant period is dangerous because of immunosuppression and there is high risk of various infections after transplantation. The most dangerous and difficult to treat are viral infections. Post transplantation prophylaxis, however, is not a simple matter because of the potential toxicity of treatments in very ill patients. Ribavirin alone is not currently considered appropriate for post-transplant prophylaxis without evidence of infection.